Facts & figures
As of: January, 2019
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992, incl. BIMSB
2) primarily from own ressources, since 2001
3) primarily from own ressources
4) since 2009
5) since 2006
6) since 2002
Research Institutions of Campus Berlin-Buch Employees (total) |
2,151 |
|
of these: | ||
Max Delbrück Center for Molecular Medicine (MDC): | 1,646 | |
Leibniz Institute of Molecular Pharmacology (FMP): | 303 | |
Klinische Forschung Charité Campus Buch: | 202 | |
Budget and third-party grants (total)1 | EUR 192 million | |
Max Delbrück Center for Molecular Medicine (MDC): | EUR 147 million | |
Leibniz Institute of Molecular Pharmacology (FMP): | EUR 29 million | |
Klinische Forschung Charité Campus Buch: | EUR 16 million | |
BiotechPark Berlin-Buch | ||
Number of companies: | 62 | |
Employees: | 800 | |
Annual revenue: Percentage of third-party grants: 3,1% |
EUR 220 million |
|
Hospitals & Patient-Care Institutions | ||
Employees (total): of these: |
3,564 | |
HELIOS Klinikum Berlin-Buch: | 2,700 | |
Evangelische Lungenklinik: | 325 | |
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik): | 89 |
|
Patient-care institutions: | 450 | |
Number of patient beds: | 1,267 | |
Patients per year (inpatient and outpatient): | 220,519 | |
Total investment volume of these: |
EUR 1.451 billion | |
Infrastructure Campus Berlin-Buch1 | EUR 624 million | |
HELIOS Klinikum Berlin-Buch² | EUR 336 million | |
Evangelische Lungenklinik3 | EUR 49 million | |
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1 | EUR 39 million |
|
LudwigPark 3 | EUR 45 million | |
Allées des Châteaux 3 | EUR 23 million | |
Widerker Vermögensverwaltung (Schlosspark-Passage) 3 | EUR 29 million |
|
Ludwig Hoffmann Quartier | EUR 152 million |
|
Housing construction associations (HOWOGE 3,4, EWG 3,5, WBG 3,6 Hau+S 3,5 ) | EUR 154 million |
News Buch Berlin
FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications
FyoniBio, a contract development organization (CDO) specializing in customized cell line and process development has partnered with BioLamina, a biotech company renowned for its expertise in extracell...
more ...Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies (Full-Life), a clinical stage, fully integrated global radiotherapeutics company today announced they have entered into an agreeme...
more ...Third ERC Grant for Gaetano Gargiulo
Cell-based immunotherapies, particularly lab-produced immune cells known as CAR T cells, show promise in treating various cancers. But how do we produce effective ones? Gaetano Gargiulo from the Max D...
more ...Events Buch Berlin
20.03.2024, 08:50
Tageswanderung "Moore und Weiden" im Bucher Forst ca. 11 km
Wanderroute: Ab S-Bahnhof Bernau, durch den Schloßpark mit der kleinsten Brücke Berlins, über Weide- und durch Moorflächen, dem Ausstichgelände Röntgental und den Skulpturenparcours“ Steine ohne Grenz...
more ...22.03.2024, 09:00
UniStem Day 2024
Das German Stem Cell Network (GSCN) lädt die an Biologie interessierten Berliner Schüler:innen (Biologie-Leistungskurse und Grundkurse) mit ihren Lehrer:innen herzlich zum UniStem Day – zum europäisch...
more ...